218 related articles for article (PubMed ID: 27998451)
1. [Pay attention to the secondary optic neuropathy and the safe appropriate applications of optic neuroprotection].
Zhong Y
Zhonghua Yan Ke Za Zhi; 2016 Dec; 52(12):881-884. PubMed ID: 27998451
[TBL] [Abstract][Full Text] [Related]
2. Optic nerve and neuroprotection strategies.
Osborne NN; Chidlow G; Layton CJ; Wood JP; Casson RJ; Melena J
Eye (Lond); 2004 Nov; 18(11):1075-84. PubMed ID: 15534592
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of recombinant human granulocyte colony-stimulating factor (G-CSF) in a rat model of anterior ischemic optic neuropathy (rAION).
Chang CH; Huang TL; Huang SP; Tsai RK
Exp Eye Res; 2014 Jan; 118():109-16. PubMed ID: 24316388
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotection in Optic Neuropathy.
Levin LA
Asia Pac J Ophthalmol (Phila); 2018; 7(4):246-250. PubMed ID: 30066502
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of neuroprotection and applications in ocular disease.
Eur J Ophthalmol; 1999; 9 Suppl 1():S52-81; quiz S82-4. PubMed ID: 10230609
[No Abstract] [Full Text] [Related]
6. Axonal loss and neuroprotection in optic neuropathies.
Levin LA
Can J Ophthalmol; 2007 Jun; 42(3):403-8. PubMed ID: 17508035
[TBL] [Abstract][Full Text] [Related]
7. Current understanding of neuroprotection in glaucoma.
Wein FB; Levin LA
Curr Opin Ophthalmol; 2002 Apr; 13(2):61-7. PubMed ID: 11880717
[TBL] [Abstract][Full Text] [Related]
8. Sustained neuroprotection from a single intravitreal injection of PGJ₂ in a nonhuman primate model of nonarteritic anterior ischemic optic neuropathy.
Miller NR; Johnson MA; Nolan T; Guo Y; Bernstein AM; Bernstein SL
Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7047-56. PubMed ID: 25298416
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotection: the next breakthrough in glaucoma? Proceedings of the Third Annual Optic Nerve Rescue and Restoration Think Tank.
Chew SJ; Ritch R
J Glaucoma; 1997 Aug; 6(4):263-6. PubMed ID: 9264307
[No Abstract] [Full Text] [Related]
10. Neuroprotection--possibilities in perspective.
Weinreb RN
Surv Ophthalmol; 2001 May; 45 Suppl 3():S241-2. PubMed ID: 11377442
[No Abstract] [Full Text] [Related]
11. Is neuroprotection a viable therapy for glaucoma?
Weinreb RN; Levin LA
Arch Ophthalmol; 1999 Nov; 117(11):1540-4. PubMed ID: 10565524
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma.
Hains BC; Waxman SG
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4164-9. PubMed ID: 16249495
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotection in glaucoma: recent and future directions.
Danesh-Meyer HV
Curr Opin Ophthalmol; 2011 Mar; 22(2):78-86. PubMed ID: 21252670
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotection in Glaucoma: Animal Models and Clinical Trials.
Almasieh M; Levin LA
Annu Rev Vis Sci; 2017 Sep; 3():91-120. PubMed ID: 28731838
[TBL] [Abstract][Full Text] [Related]
15. Retinal ganglion cells and neuroprotection for glaucoma.
Levin LA
Surv Ophthalmol; 2003 Apr; 48 Suppl 1():S21-4. PubMed ID: 12852431
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of low-dose G-CSF plus meloxicam in a rat model of anterior ischemic optic neuropathy.
Liu PK; Wen YT; Lin W; Kapupara K; Tai M; Tsai RK
Sci Rep; 2020 Jun; 10(1):10351. PubMed ID: 32587280
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotection in glaucoma: a model for neuroprotection in optic neuropathies.
Marcic TS; Belyea DA; Katz B
Curr Opin Ophthalmol; 2003 Dec; 14(6):353-6. PubMed ID: 14615639
[TBL] [Abstract][Full Text] [Related]
18. The Protective Effects of n-Butylidenephthalide on Retinal Ganglion Cells during Ischemic Injury.
Chou YY; Chien JY; Ciou JW; Huang SP
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216208
[TBL] [Abstract][Full Text] [Related]
19. Ischemic optic neuropathy as a model of neurodegenerative disorder: A review of pathogenic mechanism of axonal degeneration and the role of neuroprotection.
Khalilpour S; Latifi S; Behnammanesh G; Majid AMSA; Majid ASA; Tamayol A
J Neurol Sci; 2017 Apr; 375():430-441. PubMed ID: 28320183
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotection for glaucoma: Requirements for clinical translation.
Levin LA; Crowe ME; Quigley HA;
Exp Eye Res; 2017 Apr; 157():34-37. PubMed ID: 27955999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
